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Facile synthesis of mono- and bis-methylated Fmoc- 
Dap, -Dab and -Orn amino acids 
 
Fredrik Lindahla,b , Huy N. Hoanga , David P. Fairliea and Matthew A. Coopera,b  
A new methodology for the synthesis of side chain mono- or 
bis- methylated Fmoc-Dap, -Dab and -Orn amino acids was 
developed by probing the reactivity of commercially available 
Fmoc amino acids.  
N-methylated amino acid derivatives are often used in peptide drug 
development due to their effects in modulating the affinity of 
peptide-receptor interactions, and their potential to enhance 
bioavailability.1-4 This has driven the demand for synthetic protocols 
towards side chain mono-, di- and N(a)-methylated lysine 
derivatives and has led to the development of a vast number of lysine 
specific synthetic methods.1-3, 5 However, conversions of the shorter 
chain analogues of lysine, such as 2,3-diaminopropionic acid (Dap), 
2,4-diaminobutyric acid (Dab) and Ornithine (Orn), into N-
methylated derivatives have been less well studied. In particular, 
there is no literature precedence for installing mono-methylated 
species without the prior synthesis of either the tosyl- or nosyl-
protected species to facilitate alkylation.6, 7  
 
Literature protocols available for the synthesis of Fmoc-Dab(Me2)-
OH were first replicated and scrutinised here. These methods (A to 
D) require changing the protecting group from Boc to Fmoc in all 
cases as a final step to achieve the desired Fmoc derivative. A 
common first line approach is based on the substitution of Boc-(γ)-
bromo propionic acid intermediate with dimethyl amine.8 The (γ)-
bromo amino-acid intermediate is available via multistep syntheses, 
such as esterification of glutamic acid with 1-hydroxy-2-
thiopyridone followed by light induced radical bromination,9 or 
reduction of glutamic acid to homo-serine followed by bromination 
in the presence of PPh310 (method A). Alternatively, ring opening of 
optically pure amino-γ-butyrolactone substrates,11, 12 commercially 
available or modified e.g. Boc-methionine,13 has lead to the desired 
bromo intermediates (methods B and C). All these methods (A-C) 
require multiple step syntheses starting from the Boc-protected 
amino acid precursor as well as additional de-protection / re-
protection steps to obtain the required final Fmoc amino acid 
(Scheme 1). The alternative and more attractive method (D) is the 
Pd/C assisted reductive alkylation of Boc-Dab-OH acid substrate 
under hydrogen atmosphere and excess aqueous formal aldehyde.14 
However, in our hands method D led to a mixture of two products. 
The main product was not the Boc-Dab(Me2)-OH analogue 2a but 
rather a 6 membered cyclic pyrimidine based analogue 1 (Scheme 
2). Similar results when using other reductive reagents such as 
PdOH/C/H2 (palladium hydroxide on carbon under H2 gas) and 
NaCNBH3 (sodium cyanoborohydride) were observed (Scheme 2). 
 
 
 
The mixture was found to co-elute in LCMS traces. Careful 
purification by flash chromatography confirmed two products (1 and 
2a) in a 60:40 ratio. Further investigative 1D and 2D NMR 
experiments clearly revealed the lack of the backbone secondary 
amide proton in the pyrimidine component 1. These findings, 
together with the mass analysis identified the structure of 1. To our 
knowledge, this has not previously been reported for Dab based 
amino acids (Scheme 2). 
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Another Fmoc/Boc-Lys(Boc)-OH protection strategy that allows 
selective side chain methylation is the formation of an oxazolidinone 
ring between the alpha amine and the amino-acid  carboxylate using 
formaldehyde under acid catalysis (3).15, 16 This strategy allowed for 
the selective alkylation of the (de-protected) side chain amine 
followed by ring opening under basic conditions to restore the amino 
acid backbone17 (5). Conveniently, this 5 membered oxazolidinone 
ring 3 can also be reductively ring opened, under mild racemisation- 
free18, 19 conditions, using TFA-Et3SiH in chloroform to produce 
N(a)-methylated derivatives18, 19 of type 6 (Scheme 3).   
 
Adapting this general protocol15 for the shorter chain analogue 
amino acid Dab (n=2), the 1D and 2D NMR analysis of products 
indicated the formation of pyrimidine 4 (the Boc analog to 1) as the 
major product, with retention of the side chain Boc protection group. 
Surprisingly, the expected oxazolidinone ring formation was only 
observed as a minor side product. Similarly, the short chain Dap 
(n=1) and the longer chain Orn (n=3) cyclized with formaldehyde to 
yield a 5-membered imidazolidine ring 7, and a 7-membered 
diazepane ring 8 respectively. These initial results suggested that the 
chemistry of short chain homologues of lysine probably was driven 
by the relatively more reactive side chain amide and the formation of 
an aminal, rather than the expected 5-membered oxazolidinone ring 
3 (Scheme 3). 
 
 
 
Optimisation of the key cyclization reaction forming the pyrimidine 
ring structure 4 with Fmoc-Dab(Boc)-OH was conducted by 
employing paraformaldehyde (2-6 eq), two different solvents 
(MeCN and toluene) and catalysed by either pTsOH or 
camphorsulphonic acid (CSA). Using elevated temperature (120 °C, 
15 min) and toluene as solvent gave 10-15% of the oxazolidinone 
side product, regardless of the paraformaldehyde amount used. The 
oxazolidinone formation was supressed further when acetonitrile 
was used as solvent. Replacing the energy source with a microwave 
reactor (120 °C) resulted in the cyclic structures 4, 7 and 8 as 
exclusive products. This also allowed shortening of the reaction 
times from 15 min to 2 min, using only 2 eq of paraformaldehyde. 
Due to the high selectivity and efficiency of the cyclisation reaction 
for all three products, rapid fast flash chromatography on a silica 
plug resulted in high purity >95%.  
 
Structures 4, 7 and 8 provide potential intermediates for the selective 
synthesis of N(β,γ,δ) mono- or bis-methylated Dap, Dab and Orn 
analogues, if regioselective reductive ring opening is possible.  
 
The optimisation of the ring opening conditions of the model 
substrate 4, included various trials of hydride sources such as 
Pd/C/H2, NaBH4, NaCNBH3 and TFA-Et3SiH cocktails, in either 
MeOH or MeCN as solvent. Only the silane-based cocktail at 
elevated temperature delivered full conversion to a single N(γ)-
methylated product (9) allowing for minimal purification 
requirements.  These conditions were successfully applied to the 
other substrates, with the best results achieved when 4, 7 and 8 were 
subjected to TFA-Et3SiH (6 fold excess) in chloroform, with only a 
major single new product appearing in LCMS traces. Mass 
spectroscopic evidence of a mass gain of two amu was consistent 
with 1D and 2D NMR spectra, suggesting that a ring opening had 
occurred with exclusive formation of the Fmoc side chain mono 
methylated Dap, Dab and Orn (9-11) derivatives (Scheme 4). 
 
With the successful conversion of the cyclic intermediates 4, 7 and 8 
into N(β,γ,δ) mono-methylated products 9-11, we were interested to 
determine whether the same intermediates could be used as starting 
materials for access to the corresponding bis methylated analogues 
of Dap, Dab and Orn. To achieve this it was necessary to remove the 
Boc protecting group, alkylate and then ring open to furnish the final 
product. Using 4 as the model substrate, Boc removal was achieved 
in neat formic acid followed by concentrating the solution. 
Reductive amination using NaCNBH3 yielded the N(γ) methylated 
heterocyclic product in quantitative yield. Immediate treatment with 
TFA-Et3SiH and heating yielded the desired ring-opened bis- 
methylated product 12 quantitatively. The key intermediates 7 and 8 
followed the same trend giving products 13 and 14, also 
quantitatively (Scheme 4). 
 
 
  
 
 
These findings demonstrate that all Fmoc-Lys(Boc)-OH  analogues 
with shorter side chain length (n=1-3; Dap, Dab, Orn) can be 
cyclized with formaldehyde under optimised conditions to 
exclusively give the corresponding aminal ring structures (4, 7 and 
8). In contrast, the oxazolidinone 3 is formed as the main product 
from Fmoc-Lys(Boc)-OH (n=4). The side chain length seemed in all 
cases to be the major contributing factor in the preference for this 
reaction pathway. In the lysine case the thermodynamically more 
stabile oxazolidinone ring was formed18 rather than the theoretically 
possible 8 membered aminal-tethered heterocycle. In the case of 
Dap, Dab and Orn analogues the 5-7 membered N-C-N rings 
imidazolidine, pyrimidine and diazepine rings (4, 7 and 8), were the 
respective preferred products, with any preference for the 5-
membered ring system offset by the reactivity of the side chain 
amine in all three cases. 
 
Ring opening of the key ring structures was facilitated under ionic 
hydrogenation conditions. The most effective system was found to 
be TFA-Et3SiH, requiring mild to moderate heating to furnish full 
conversions. The regioselective preference of the ring opening could 
possibly be due to the inability of the electron depleted Fmoc-amide 
nitrogen to collapse the protonated aminal, giving rise to exclusive 
formation of the side chain mono methylated products 9-11, in a 2 
step one pot reaction. Similarly bis-methylated products 12-14 were 
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also obtained from the key intermediates 4, 7 and 8 via Boc 
deprotection, N-alkylation followed by ring opening, a 4-step in one-
pot sequence. Further, this one pot methodology was fully scalable 
to multi-gram synthesis of the mono methylated Dab derivative 9, 
with an overall yield of 95% after Boc protection. In summary, a 
quick, facile and scalable protocol for the selective synthesis of 
mono- and bis-methylated Fmoc-Dap/Dab/Orn-OH amino acid 
building blocks was established, based on commercially available 
starting materials using standard lab equipment.  
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